SCHEDULE 13D//SEC Filing
LakeShore Biopharma Co., Ltd. SCHEDULE 13D
Accession 0001213900-25-066359
CIK 0002078050other
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 8:57 AM ET
Size
229.7 KB
Accession
0001213900-25-066359
Documents
- SCHEDULEprimary_doc.xml
- EX-99.1ea024982001ex99-1_lakeshore.htm
JOINT FILING AGREEMENT, DATED JULY 22, 2025, AMONG THE REPORTING PERSONS
- EX-99.2ea024982001ex99-2_lakeshore.htm
SHARE AND WARRANT PURCHASE AGREEMENT, DATED JULY 8, 2025, BY AND BETWEEN THE ISSUER AND CRYSTAL INVESTMENT
- GRAPHICex99-2_001.jpg
GRAPHIC
- GRAPHICex99-2_002.jpg
GRAPHIC
- GRAPHICex99-2_003.jpg
GRAPHIC
Issuer
Crystal Peak Investment Inc.
CIK 0002078050
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0002078050
Filing Metadata
- Form type
- SCHEDULE 13D
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 8:57 AM ET
- Size
- 229.7 KB